Usa India city Sanofi testing RNA vaccine Usa India city Sanofi

Sanofi to start human trials of its second Covid vaccine candidate

Reading now: 536
www.livemint.com

Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.Also Read | Vaccine confidence in India is ticking more boxes nowThe phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.Phase 3 would be carried out on many more patients to determine its effectiveness.The first trials will include 415 people, with inital results expected in the third quarter.Messenger RNA technology is also used in the Pfizer/BioNTech and Moderna vaccines, already authorised in the.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA